Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - FREE CASH FLOW
Free Cash Flow AVTX - Avalo Therapeutics, Inc.
-30.8 M
LAST VALUE
34.10%
2 YEAR CAGR
-52.88%
5 YEAR CAGR
-10.35%
10 YEAR CAGR